Monoclonal Antibody Therapy in Treating Patients With Lymphoma or Leukemia

Completed · Phase 1/Phase 2

Conditions studied: Leukemia, Lymphoma

In brief

RATIONALE: Monoclonal antibodies can locate cancer cells and either kill them or deliver cancer-killing substances without harming normal cells. PURPOSE: Phase I/II trial to study the effectiveness of monoclonal antibody therapy in treating patients who have lymphoma or leukemia.

Key facts

Study ID

NCT00003874

Run by

Fred Hutchinson Cancer Center

Starts

1999-02-01

Expected to finish

2001-09-01

Last updated by the study team

2011-11-29

Who can join

Age: any, up to 70. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Fred Hutchinson Cancer Research Center — Seattle, Washington, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.